of financial implications for patient safety and quality improvement initiatives. This miniseminar will focus on actual economic implications of current patient safety and quality improvement (PSQI) measures and programs. We will discuss how the changing healthcare landscape incorporates PSQI within the scope of reimbursement and financial penalties. The Massachusetts Medical Society (MMS) has been on the forefront of advocating and even going as far as to litigate on behalf of protecting physicians and ensuring fair application of quality metrics towards physicians. The President of the MMS, Dr. Alice Coombs, and Elaine Kishenbaum, VP of Policy, Planning, Member Services of the MMS will present updates on the current legal action between the Society and the Group Insurance Corporation in Massachusetts which has been performing physician tiering. Further, they will both discuss the emerging concept of global payment and payment reform. The role of the physician in advocating for and protecting ourselves will be expounded upon. The president of the Massachusetts Society of Otolaryngology (who is an active clinician) will discuss the financial effect that physician tiering has on his group and the impact of this for the patients in their group. He will also discuss the potential impact of payment reform on their practice. The further effects on other otolaryngologists in Massachusetts will be discussed. The co-chair of the Patient Safety and Quality Improvement Committee will present tangible ways in which physicians can embed PSQI into their practice and develop their own metrics so that they can demonstrate to patients, hospitals, insurers, and regulatory agencies that they are practicing continuous quality improvement. Such data will inevitably be necessary as physicians will need to demonstrate the high quality of care which we are known to provide. EDUCATIONAL OBJECTIVES: 1) Describe the current economic forces affecting patient safety and quality improvement in your practice. 2) Explain how Massachusetts physicians navigate the economic landscape which includes payer reform and physician tiering. 3) Be able to implement metrics into your practice to be proactive against these economic forces.
Evidence and Innovation in Management of CRS
Rakesh Chandra, MD (moderator); Alexander Chiu, MD; Raj Sindwani, MD, FRCS; Joseph Han, MD; Pete Batra, MD PROGRAM DESCRIPTION: Management of chronic rhinosinusitis (CRS) has undergone continuous evolution through advances in technology. Many of these innovations have promoted minimally invasive management of complicated pathologies, including neoplastic disease. Such innovations have also facilitated treatment of uncomplicated sinus disease with subjective improvements in recovery. The current era in management of CRS was inspired by the proliferation of endoscopy, and the introduction of both the microdebrider and image guided surgical navigation. More recent innovations have been in the areas of electrosurgery, balloon dilatation, CT scanning (in-office, intraoperative), and paranasal sinus biomaterials. Further advances in powered instrumentation and image guidance have also continued to expand the boundaries of endoscopic sinus surgery. There are no currently established guidelines regarding when each of the available technological innovations should be applied, although there is increasing clinical experience and evidence based data regarding how these modalities may expand the scope of rhinologic practice. This panel will present available clinical and scientific data regarding the safety and efficacy of recent technological innovations in the management of CRS. The potential roles for each of these modalities in both the operative and outpatient settings will be discussed. An evidence based algorithm for the application of each innovation will be presented. The panelists consist of experienced academic rhinologists and sinus surgeons who represent six academic tertiary centers. The panelists also lead in funded research for innovations to optimize the management of both basic and complicated sinonasal pathologies. EDUCATIONAL OBJECTIVES: 1) Develop a rational algorithm for applying technological innovations in the outpatient and operative setting. 2) Discuss clinical and scientific evidence for the safety, efficacy, and benefits of selected technological innovations. 3) Recognize the variety of technological tools available for management of patients with chronic rhinosinusitis.
Evidence Based Medical Management of Chronic Rhinosinusitis
Joseph Han, MD (moderator); Peter Hwang, MD; Todd Kingdom, MD; Richard Orlandi, MD PROGRAM DESCRIPTION: The purpose of this miniseminar is to present and discuss the etiology and pathophysiology for chronic rhinosinusitis (CRS). As the scientific community gains better understanding for the development and management of CRS, we realize that medical management is vital to improving the quality of life in these patients and that surgical treatment does not always provide a cure for them. However, the medical treatment of CRS continues to remain a challenge for many otolaryngologists. Systemic and topical antibiotics, antifungals, corticosteroids, and immunomodulators are just some examples of the medications being used. Otolaryngologists are desperate for an effective treatment for their symptomatic patients who have CRS. Since there are no current guidelines, consensuses, or recognized standards of care in medical management of CRS, many otolaryngologists have to fall back on their resident training, experience, and lectures to decide management choices. The panel will discuss the current evidence-based practice that is available in medically managing patients with CRS through a multimedia PowerPoint presentation. Often, initial and conventional management will fail and even be recalcitrant to surgical management. The panelist will then discuss why some CRS is refractory to the initial medical management and discuss alternate medical therapies that are currently being evaluated for recalcitrant CRS, as well the evidence behind these alternative options. The panel will consist of fellowship-trained rhinologists who are all directors for the rhinology division at their respective academic medical schools. They have a vast experience in treating patients with CRS, have published many peer-reviewed research articles, and are leading funded research in CRS. The combined experience of the panelists will bring a unique perspective for this difficult disease process to the academy audience. Clinical cases will be used to highlight for the audience the salient principles of the presentation. Audience participation will be encouraged through the use of the audience response system to stress key points throughout the course of the miniseminar. Specific topics that the panel will address: 1) Systemic and topical antibiotics; 2) Systemic and topical antifungals; 3) Systemic and topical immunomodulators; 4) Systemic pharmacotherapy and immunotherapy as it relates to CRS. EDUCATIONAL OBJECTIVES: 1) Understand the etiology and pathophysiology of chronic rhinosinusitis (CRS). 2) Learn an evidence-based practice approach in medically managing patients with CRS. 3) Understand why some CRS is refractory to initial medical management and appreciate alternative medical therapies.
Getting Published: How to Write Review Articles
Richard Rosenfeld, MD, MPH (moderator); Martin Burton, DM, FRCS; Neil Bhattacharyya, MD PROGRAM DESCRIPTION: This miniseminar, taught by editors from the Cochrane Collaboration and Otolaryngology-Head and Neck Surgery journal, will help attendees maximize their success in getting a review article published. High quality review articles are urgently needed in otolaryngology as a basis for continuing education, practice guidelines, clinical consensus statements, and continuous quality improvement. Moreover, review articles are read and cited more than any other article in medical journals. Systematic reviews use explicit and reproducible criteria to assemble, appraise, and combine articles with a minimum of bias. In contrast, narrative review is based largely on unstructured expert opinion. Although some topics may be suited for narrative review, a systematic approach is almost always more valid, even when dealing with observational studies. Meta-analysis builds upon systematic review by using statistical techniques to pool and summarize data. Emphasis is placed on understanding how bias can creep into the review process and what techniques can be used to minimize the problem. Heterogeneity and study quality will also be considered. Last, ten specific steps in performing a successful review will be outlined, stressing the practical implications of each with specific examples from the otolaryngology literature.
EDUCATIONAL OBJECTIVES: 1) Distinguish between systematic review, meta-analysis, and narrative review. 2) Understand techniques for minimizing bias when conducting and publishing a review. 3) Learn 10 key steps that will maximize validity and impact for a review article.
Granulomatous Diseases of the Nose and Paranasal Sinuses
Matteo Trimarchi, MD (moderator); Pete Batra, MD; Valerie J Lund, MD, FRCS, FRCSEd; Donald Lanza, MD, MS; Bozena Wrobel, MD PROGRAM DESCRIPTION: The nose and paranasal sinuses may play host to a large range of systemic granulomatous diseases. The principal element of these diseases is granuloma formation consisting of a conglomerate of macrophages, epithelioid cells, and multinucleated giant cells. This configuration is present in a number of conditions, including infectious (spirochetes [syphilis, yaws] , mycobacteria [tuberculosis, leprosy] , bacteria [rhinoscleroma], and fungus [aspergillus]) and inflammatory (Wegener granulomatosis, sarcoidosis, Churg-Strauss syndrome, cocaine induced midline destructive lesions). Many of these lesions present with non-specific sinonasal symptoms and may progress rapidly to involve contiguous structures, such as the orbit and skull base, presenting significant clinical implications for timely diagnosis and management. Thorough diagnostic workup, including endoscopic, radiologic, histopathologic and serologic testing is imperative to arrive at the proper diagnosis and to initiate appropriate local and systemic treatment. Granulomatous diseases of the nose and sinuses represent an uncommon but clinically important and potentially lethal group of disorders encountered in otolaryngologic practice. A high index of suspicion, coupled with timely diagnosis and appropriate medical and surgical management, is required in this patient population. This miniseminar will introduce the participants to the current diagnostic and classification scheme of infectious, inflammatory, and neoplastic granulomatous conditions affecting the sinonasal tract. Pertinent endoscopic, radiologic and histologic findings will be highlighted in order to exemplify the typical clinical picture of these granulomatous diseases. Contemporary management strategies, including topical sinonasal and systemic therapies and the role of sinonasal surgery will be reviewed. The miniseminar faculty will be comprised of rhinologists with internationally recognized expertise in management of these disorders. EDUCATIONAL OBJECTIVES: 1) Understand the classification for infectious, inflammatory, and neoplastic granulomatous diseases of nose and sinuses. 2) Recognize the salient endoscopic, radiographic, histologic, and serologic features in patients with granulomatous disease. 3) Appreciate the appropriate medical and surgical management strategies in the patient population.
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